Drug Type Small molecule drug |
Synonyms PLD-104 |
Target |
Action inhibitors |
Mechanism RET inhibitors(Tyrosine-protein kinase receptor RET inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
RET fusion-positive Non-Small Cell Lung Cancer | Discovery | South Korea | 30 Jan 2022 |